Results 201 to 210 of about 3,780 (219)

[Anticholinergic antiparkinson agents].

, 1988
P Taurand
openalex  

Some of the next articles are maybe not open access.

Related searches:

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

[Synthesis and testing of potential antiparkinson agents. 2. Biologically active silicium derivatives].

, 1977
Gerhard Friedrich, R. Bartsch, Klaus Rühlmann   +2 more
openalex  

[Drug information: antiparkinson agents. I. Anticholinergic agents].

Sygeplejersken, 1981
openaire   +1 more source

Problems in pharmacological evaluation of potential antiparkinson agents.

Activitas nervosa superior, 1978
J, Metysová, J, Metys, A, Dlabac
openaire   +1 more source

Analysis of Antipsychotic Induced Concomitant Prescribingof Antiparkinson Agents in Korea

, 2012
Park So Huon, Yu Jeung Lee
openalex  

[A new antiparkinson agent. Pergolide].

Ugeskrift for laeger, 1995
openaire   +1 more source

Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Ca-A Cancer Journal for Clinicians, 2009
exaly  

[The effect of a new antiparkinson agent, Selegilin, on psychomotor performance in humans].

, 1985
W Müller-Limmroth
openalex